Correlates of Myobacterium tuberculosis infection in a prison population

European Respiratory Journal

Volumn 25, Issue 6, 2005, Pages 1070-1076

  Carbonara, S ^a   Babudieri, S ^c   Longo, B ^d   Starnini, G ^e   Monarca, R ^e   Brunetti, B ^d   Andreoni, M ^d   Pastore, G ^a   De Marco, V ^b   Rezza, G ^d   Sardu, A ^f   Quercia, G ^g   Vullo, S ^h   Casti, A ⁱ   Novati, S ^j   Mazzarello, G ^k   Diena, M ^l   Romano, A ^m   Iovinella, V ^j   Florenzano, G ⁿ  

^a UNIVERSITY OF BARI   (Italy)

^b Bari Jail   (Italy)

^c UNIVERSITY OF SASSARI   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

^e BELCOLLE HOSPITAL   (Italy)

^f Casa Circondariale Femminile   (Italy)

^g Casa di Reclusione   (Italy)

^h Casa Circondariale   (Italy)

ⁱ Casa Circondariale   (Italy)

^j NONE   (Italy)

^k Casa Circondariale   (Italy)

^l Casa Circondariale   (Italy)

^m Casa Circondariale   (Italy)

ⁿ Casa Circondariale   (Italy)

more..

Author keywords

Inmates; Myobacterium tuberculosis; Prisons; Tuberculin skin testing; Tuberculosis

Indexed keywords

TUBERCULIN;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DETENTION; DISEASE TRANSMISSION; EDUCATION; EUROPE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INFECTION RISK; ITALY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PRISON; RISK FACTOR; SCREENING TEST; SOCIOECONOMICS; SPUTUM SMEAR; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS CONTROL; ADDICTION; AGE DISTRIBUTION; COMORBIDITY; CROSS-SECTIONAL STUDY; EDUCATIONAL STATUS; HEALTH SURVEY; MIGRATION; PRISONER; SEX RATIO; STATISTICAL MODEL; STATISTICS; TUBERCULOSIS;

ADULT; AGE DISTRIBUTION; COMORBIDITY; CROSS-SECTIONAL STUDIES; EDUCATIONAL STATUS; EMIGRATION AND IMMIGRATION; FEMALE; HEALTH SURVEYS; HIV INFECTIONS; HUMANS; ITALY; LOGISTIC MODELS; MALE; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; PRISONERS; SEX DISTRIBUTION; STATISTICS; SUBSTANCE-RELATED DISORDERS; TUBERCULOSIS;

EID: 20444435056     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.05.00098104     Document Type: Article

References (54)

1. World Health Organization. Tuberculosis control in prisons. A Manual for Programme Managers. WHO/CDS/TB/ 2000.281. Geneva, World Health Organization, 2000.
2. Stead WW. Undetected tuberculosis in prison. Source of infection for the community at large. JAMA 1978; 240: 2544-2547.
3. Jones TF, Craig AS, Valway SE, Woodley CL, Schaffner W. Transmission of tuberculosis in a jail. Ann Intern Med 1999; 131: 557-563.
4. Centers for Disease Control and Prevention. Tuberculosis outbreaks in prison housing units for HIV-infected inmates: California, 1995-1996. MMWR Morb Mortal Wkly Rep 1999; 48: 79-82.
5. McLaughlin SI, Spradling P, Drociuk D, Ridzon R, Pozsik CJ, Onorato I. Extensive transmission of Mycobacterium tuberculosis among congregated, HIV-infected prison inmates in South Carolina, United States. Int J Tuberc Lung Dis 2003; 7: 665-672.
6. Jochem K, Tannenbaum TN, Menzies D. Prevalence of tuberculin skin test reactions among prison workers. Can J Public Health 1997; 88: 202-206.
7. Steenland K, Levine AJ, Sieber K, Schulte P, Aziz D. Incidence of tuberculosis infection among New York State prison employees. Am J Public Health 1997; 87: 2012-2014.
8. Cone JE, Harrison R, Katz E, Chan J, Dewsnup D, Osorio AM. Tuberculosis transmission to prison employees during an outbreak among prisoners at two California prisons. J Healthcare Safety 2000; 4: 75-79.
9. Centers for Disease Control and Prevention. Tuberculosis transmission in multiple correctional facilities: Kansas, 2002-2003. MMWR Morb Mortal Wkly Rep 2004; 53: 734-738.
10. Jones TF, Craig AS, Valway SE, Woodley CL, Schaffner W. Transmission of tuberculosis in a jail. Ann Intern Med 1999; 131: 557-563.
11. Fernandez de la Hoz K, Inigo J, Fernandez-Martin JI, et al. The influence of HIV infection and imprisonment on dissemination of Mycobacterium tuberculosis in a large Spanish city. Int J Tuberc Lung Dis 2001; 5: 696-702.
12. World Health Organization. Tuberculosis in prisons. http://www.who.int/tb/dots/prisons/story_1/en. Date last accessed: March 7 2004. Date last updated: January 2005.
13. Valway SE, Greifinger RB, Papania M, et al. Multidrug-resistant tuberculosis in the New York State prison system, 1990-1991. J Infect Dis 1994; 170: 151-156.
14. Spradling P, Nemtsova E, Aptekar T, et al. Anti-tuberculosis drug resistance in community and prison patients, Orel Oblast, Russian Federation. Int J Tuberc Lung Dis 2002; 6: 757-762.
15. Pleumpanupat W, Jittimanee S, Akarasewi P, et al. Resistance to anti-tuberculosis drugs among smear-positive cases in Thai prisons 2 years after the implementation of the DOTS strategy. Int J Tuberc Lung Dis 2003; 7: 472-477.
16. Toungoussova OS, Mariandyshev A, Bjune G, Sandven P, Caugant DA. Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates in the Archangel prison in Russia: predominance of the W-Beijing clone family. Clin Infect Dis 2003; 37: 665-672.
17. Reyes H, Coninx R. Pitfalls of tuberculosis programmes in prisons. BMJ 1997; 315: 1447-1450.
18. Bellin EY, Fletcher DD, Safyer SM. Association of tuberculosis infection with increased time in or admission to the New York City jail system. JAMA 1993; 269: 2228-2231.
19. Coninx R, Eshaya-Chauvin B, Reyes H. Tuberculosis in prisons. Lancet 1995; 346: 1238-1239.
20. MacIntyre CR, Kendig N, Kummer L, Birago S, Graham NM. Impact of tuberculosis control measures and crowding on the incidence of tuberculous infection in Maryland prisons. Clin Infect Dis 1997; 24: 1060-1067.
21. Hammet TM, Gaiter JL, Crawford C. Reaching seriously at-risk populations: health interventions in criminal justice settings. Health Educ Behav 1998; 25: 99-120.
22. Coninx R, Maher D, Reyes H, Grzemska M. Tuberculosis in prisons in countries with high prevalence. BMJ 2000; 320: 440-442.
23. Anderson KM, Keith EP, Norsted SW. Tuberculosis screening in Washington state male correctional facilities. Chest 1986; 89: 817-821.
24. Pelletier AR, DiFerdinando GT Jr, Greenberg AJ, et al. Tuberculosis in a correctional facility. Arch Intern Med 1993; 153: 2692-2695.
25. Koo DT, Baron RC, Rutherford GW. Transmission of Mycobacterium tuberculosis in a California State Prison, 1991. Am J Public Health 1997; 87: 279-282.
26. Tulsky JP, White MC, Dawson C, Hoynes TM, Goldenson J, Schecter G. Screening for tuberculosis in jail and clinic follow-up after release. Am J Public Health 1998; 88: 223-226.
27. Saunders DL, Olive DM, Wallace SB, Lacy D, Leyba R, Kendig NE. Tuberculosis screening in the federal prison system: an opportunity to treat and prevent tuberculosis in foreign-born populations. Public Health Rep 2001; 116: 210-218.
28. Lobato MN, Leary LS, Simone PM. Treatment for latent TB in correctional facilities: a challenge for TB elimination. Am J Prev Med 2003; 24: 249-253.
29. Hussain H, Akhtar S, Nanan D. Prevalence of and risk factors associated with Mycobacterium tuberculosis infection in prisoners, North West Frontier Province, Pakistan. Int J Epidemiol 2003; 32: 794-799.
30. Martin V, Gonzalez P, Cayla JA, et al. Case-finding of pulmonary tuberculosis on admission to a penitentiary centre. Tuber Lung Dis 1994; 75: 49-53.
31. Martin Sanchez V, Alvarez-Guisasola F, Caylà JA, Alvarez JL. Predictive factors of Mycobacterium tuberculosis infection and pulmonary tuberculosis in prisoners. Int J Epidemiol 1995; 24: 630-636.
32. Starnini G, Lepri F, Squarcione S, Brunetti B, Gruppo di lavoro sulla TBC negli Istituti Penitenziari. Linee guida per la gestione della tubercolosi nelle carceri italiane [Working group on TB in Correctional Facilities. Guidelines for the management of tuberculosis in Italian prisons]. Bollettino per le farmacodipendenze e l'alcolismo 1997; 3: 32-37.
33. Ministero della giustizia, Dipartimento dell' Amministrazione Penitenziaria, Ufficio per lo Sviluppo e la Gestione del Sistema Informativo Automatizzato, Sezione statistica. Rilevazione semestrale tossicodipendenza e infezione da HIV negli Istituti penitenziari [Biannual assessment of drug addiction and HIV infection in the correctional institutes]. Rome, Dept of Correctional Facilities, Ministry of Justice, 2003; pp. 5-57.
34. Istituto Superiore di Sanità. Aggiornamento dei casi di AIDS notificati in Italia al 31 dicembre 2002 [The National Institute of Health. Update of AIDS cases notified in Italy, 2002]. Notiziario dell' Istituto Superiore di Sanità 2003; 16: Suppl. 1, 1-14.
35. Centers for Disease Control and Prevention. Core curriculum on tuberculosis. Atlanta, Centers for Disease Control and Prevention, 2000.
36. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep 2000; 49: 1-51.
37. Hammett TM, Harmon MP, Rhodes W. The burden of infectious disease among inmates of and releases from US correctional facilities, 1997. Am J Public Health 2002; 92: 1789-1794.
38. White MC, Tulsky JP, Goldenson J, Portillo CJ, Kawamura M, Menendez E. Randomized controlled trial of interventions to improve follow-up for latent tuberculosis infection after release from jail. Arch Intern Med 2002; 162: 1044-1050.
39. Conklin TJ, Lincoln T, Flanigan TP. A public health model to connect correctional health care with communities. Am J Public Health 1988; 88: 1249-1250.
40. World Heath Organization. Immunological Basis for Immunization/Module 5: Tuberculosis. WHO/EPI/GEN/93.15. Geneva, World Health Organization, 1993.
41. Fine PEM, Ponnighaus JM, Maine NP. The distribution and implications of BCG scars in Northern Malawi. Bull World Health Organ 1989; 67: 35-42.
42. Hizel K, Maral I, Karakus R, Aktas F. The influence of BCG immunisation on tuberculin reactivity and booster effect in adults in a country with a high prevalence of tuberculosis. Clin Microbiol Infect 2004; 10: 980-983.
43. Bowerman RJ. Tuberculin skin testing in BCG-vaccinated populations of adults and children at high risk for tuberculosis in Taiwan. Int J Tuberc Lung Dis 2004; 8: 1228-1233.
44. Al Zahrani K, Al Jahdali H, Menzies D. Does size matter? Utility of size of tuberculin reactions for the diagnosis of mycobacterial disease. Am J Respir Crit Care Med 2000; 162: 1419-1422.
45. Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald RK. A meta-analysis of the effect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements. Thorax 2002; 57: 804-809.
46. WHO-UNICEF. Estimates of BCG coverage 1980-2003. http://www.who.int/vaccines/globalsummary/timeseries/tswucoveragebcg.htm. Date last accessed: March 8 2005.
47. World Health Organization. Issues relating to the use of BCG in immunization programmes. A discussion document. WHO/V&B/99.23. http://www.who.int/vaccines-documents/DocsPDF99/www9943.pdf. Date last accessed: March 8 2005.
48. D'Amelio R, Stroffolini T, Biselli R, et al. Tuberculin skin reactivity in Italian military recruits tested in 1996-1997. Eur J Clin Microbiol Infect Dis 2000; 19: 200-204.
49. Dutt AK, Stead WW. Tuberculosis in the elderly. Med Clin North Am 1993; 77: 1353-1368.
50. Codecasa LR, Porretta AD, Gori A, et al. Tuberculosis among immigrants from developing countries in the province of Milan, 1993-1996. Int J Tuberc Lung Dis 1999; 3: 589-595.
51. EuroTB (InVS/KNCV) and the national coordinators for tuberculosis surveillance in the WHO European Region. Surveillance of tuberculosis in Europe. Report on tuberculosis cases notified in 2001. Saint-Maurice, Institut de veille sanitaire, 2003.
52. Cantwell MF, McKenna MT, McCray E, Onorato IM. Tuberculosis and race/ethnicity in the United States: impact of socioeconomic status. Am J Respir Crit Care Med 1998; 157: 1016-1020.
53. Reichman LB, Felton CP, Edsall JR. Drug dependence: a possible new risk factor for tuberculosis disease. Arch Intern Med 1979; 139: 337-339.
54. Centers for Disease Control and Prevention. Prevention and control of tuberculosis in correctional facilities. MMWR Morb Mort Wkly Rep 1996; 45: 6-14.